Metformin or Acarbose Treatment Significantly Reduced Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Low-Grade Albuminuria.
CONCLUSIONS In a group of Chinese patients with newly diagnosed type 2 diabetes mellitus, low-grade albuminuria (baseline UACR of 10-30 mg/g) was associated with metabolic factors before treatment. Treatment with either metformin or acarbose significantly reduced albumin excretion.
PMID: 30531690 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
More News: Acarbose | Biomedical Science | Cardiology | Cardiovascular | China Health | Cholesterol | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fortamet | Heart | Insulin | Metformin | Research | Science | Study